Rockies release veteran third baseman Casey Blake

6 Comments

Casey Blake talked about possibly retiring following September neck surgery, but instead signed a non-guaranteed one-year deal with the Rockies and entered spring training atop the third base depth chart.

Today the Rockies released Blake after the 37-year-old went just 3-for-20 with seven strikeouts while showing signs of not being fully healthy.

This may be the end of the line for Blake, who went from career minor leaguer to quality regular for the Indians and Dodgers despite not getting an extended chance in the majors until age 29. He hit just .252 with a .713 OPS in 63 games in between disabled list stints last season and had similarly mediocre production in 2010.

Blake would have earned $2 million for making the Opening Day roster, but instead Colorado will go with rookies Jordan Pacheco and Chris Nelson at third base until 21-year-old stud prospect Nolan Arenado is ready.

MLB, union resume blood testing after pandemic, lockout

Scott Taetsch-USA TODAY Sports
1 Comment

NEW YORK – In the first acknowledgment that MLB and the players’ association resumed blood testing for human growth hormone, the organizations said none of the 1,027 samples taken during the 2022 season tested positive.

HGH testing stopped in 2021 because of the COVID-19 pandemic. Testing also was halted during the 99-day lockout that ended in mid-March, and there were supply chain issues due to COVID-19 and additional caution in testing due to coronavirus protocols.

The annual public report is issued by Thomas M. Martin, independent program administrator of MLB’s joint drug prevention and treatment program. In an announcement accompanying Thursday’s report, MLB and the union said test processing is moving form the INRS Laboratory in Quebec, Canada, to the UCLA Laboratory in California.

MLB tests for HGH using dried blood spot testing, which was a change that was agreed to during bargaining last winter. There were far fewer samples taken in 2022 compared to 2019, when there were 2,287 samples were collected – none positive.

Beyond HGH testing, 9,011 urine samples were collected in the year ending with the 2022 World Series, up from 8,436 in the previous year but down from 9,332 in 2019. And therapeutic use exemptions for attention deficit hyperactivity disorder dropped for the ninth straight year, with just 72 exemptions in 2022.

Overall, the league issued six suspensions in 2022 for performance-enhancing substances: three for Boldenone (outfielder/first baseman Danny Santana, pitcher Richard Rodriguez and infielder Jose Rondon, all free agents, for 80 games apiece); one each for Clomiphene (Milwaukee catcher Pedro Severino for 80 games), Clostebol (San Diego shortstop Fernando Tatis Jr. for 80 games) and Stanozolol (Milwaukee pitcher J.C. Mejia for 80 games).

There was an additional positive test for the banned stimulant Clobenzorex. A first positive test for a banned stimulant results in follow-up testing with no suspension.